MétaCan
Menu
← Retour à la cohorte
Enregistrement W4415972259 · doi:10.1101/2025.11.04.25339466

Effects of polygenic risk score communication on health outcomes: systematic review and meta-analysis

2025· preprint· W4415972259 sur OpenAlexaff
Luigi Russo, Nicolò Lentini, Sara Farina, Antonio Cristiano, Andrea Adduci, Alessio Perilli, Christian Cao, Roberta Pastorino, Stefania Boccia, John P. A. Ioannidis

Notice bibliographique

RevuemedRxiv · 2025
Typepreprint
Langue
DomaineBiochemistry, Genetics and Molecular Biology
ThématiqueBRCA gene mutations in cancer
Établissements canadiensUniversity of Toronto
Organismes subventionnairesEuropean Commission
Mots-clésMeta-analysisRandomized controlled trialPolygenic risk scoreDiseaseFramingham Risk ScoreSystematic reviewMEDLINERisk assessment

Résumé

récupéré en direct d'OpenAlex

Abstract Objective The purpose of this systematic review and meta-analysis is to summarize evidence from all RCTs to-date on the efficacy of polygenic risk score (PRS) communication in changing health outcomes. Design Systematic review and meta-analysis. Data sources Cochrane Central Register of Controlled Trials (CENTRAL) and Pubmed, from inception to March 2025. Study selection Randomized controlled trials comparing disclosure versus non-disclosure of PRS results. Intervention included comunication of risk information from ≥ 2 single nucleotide polymorphism (SNPs). Methods Pairs of reviewers conducted screening, extracted data and assessed risk of bias. Meta-analyses were conducted using inverse variance-weighting with fixed and random effects models. Otto-SR was used to verify screening and data extraction. Risk of bias was assessed with the Cochrane Risk of Bias 2 (RoB-2) tool. All measurable health-related outcomes were considered eligible. Results Of 7,830 articles retrieved, 27 RCTs were eligible. PRSs mainly predicted risks for cancer (n=9 RCTs), cardiovascular diseases (n=8), and diabetes (n=6). 21 RCTs targeted primarily healthy populations, 3 at-risk populations and 3 individuals who had already developed a disease and PRS predicted complications. 15/26 RCTs concluded in their abstracts with favorable claims about the PRS, with only 5/15 justifying it with any statistically significant results. 9/26 RCTs had high risk of bias. Meta-analysis revealed no statistically significant effects on any measured outcome, among 22 outcomes tested in 2 or more trials. Standardized mean differences (SMDs) (95% CI) for dietary outcomes were −0.11 (−0.23; 0.01) for daily energy intake, 0.08 (−0.15; 0.31) for daily fat intake and −0.11 (−0.28; 0.06) for alcohol consumption. For physical activity, SMD was −0.01 (−0.13; 0.11). Relative risks were 1.12 (0.77; 1.61) for screening attendance, 1.50 (0.98; 2.29) for statin use, and 0.95 (0.32; 2.79) for disease incidence. For psychological outcomes, SMDs were −0.02 (−0.13; 0.08) for anxiety, −0.06 (−0.23; 0.10) for worry, −0.10 (−0.40-0.19) for perceived risk, and −0.05 (−0.23; 0.13) for depression. For clinical outcomes, mean differences were −2.01 (−8.27; 4.26) for total cholesterol, −3.64 (−7.88; 0.60) for LDL cholesterol, −0.21 (−2.65; 2.23) for HDL cholesterol, −1.88 (−4.17;0.42) for diastolic blood pressure, −1.26 (−4.44; 1.92) for systolic blood pressure, −0.12 (−0.64; 0.39) for BMI and −0.33 (−0.87; 0.20) for weight. 69 outcomes had been reported in only a single trial (18/69 primary ones), and of those 2 had statistically significant results at p<0.05 as primary outcomes and 3 as secondary outcomes. Conclusions Overall, despite frequent promising claims, the disclosure of PRS typically did not lead to meaningful changes in behavioral, psychological or clinical outcomes. Systematic review registration OpenScience Framework: doi.org/10.17605/OSF.IO/28V6J Summary box Section 1: What is already known on this topic - Polygenic risk scores (PRSs) represents one of the most promising approaches of personalized medicine where communication of genetic information is expected to improve behavior and health outcomes. - Previous reviews have evaluated the communication of genetic risk but none have evaluated yet the effect of specifically PRS. - Since PRSs implementation in clinical practice is contemplated, rigorous evaluation of their impact is valuable for further implementation. Section 2: What this study adds - PRS communication effects were close to null for a large set of outcomes, demonstrating no improvement in preventive behaviours, including screening adherence or clinical measures. - High heterogeneity in RCTs in the field is present with small sample sizes, short follow-up periods, and many self-reported outcomes. - A gap is evident between the theoretical promise of PRS-guided prevention and its lack of documented real-world effectiveness.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,023
score de la tête « metaresearch » (Gemma)0,058
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesMétarecherche
Catégories consensuellesaucune
DomaineSignal candidat: Méthodes · Signal consensuel: aucune
Devis d'étudeSignal candidat: Méta-analyse · Signal consensuel: Méta-analyse
GenreSignal candidat: Synthèse · Signal consensuel: Synthèse
Score de désaccord entre enseignants0,977
Score d'incertitude au seuil0,123

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0230,058
Méta-épidémiologie (sens strict)0,0030,002
Méta-épidémiologie (sens large)0,0240,038
Bibliométrie0,0090,009
Études des sciences et des technologies0,0010,001
Communication savante0,0040,003
Science ouverte0,0020,002
Intégrité de la recherche0,0030,002
Charge utile insuffisante (le modèle a refusé de juger)0,0040,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,032
Tête enseignante GPT0,340
Écart entre enseignants0,307 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Devis d'étudeMéta-analyse
DomaineMéthodes
GenreSynthèse

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revuemedRxiv→Même sujetBRCA gene mutations in cancer→Travaux en français237 207→